All News

BOSTON -- An endoscopic surgical procedure to treat symptomatic gastroesophageal reflux disease (GERD) was safe and effective over a three-year follow-up, found researchers here.

KING OF PRUSSIA, Pa. -- With smoking bans extending to even the traditionally smoke-filled congressional Speaker's Lobby, a new tobacco-suffused hand gel called Nicogel promises to banish smokers' cravings for up to four hours.

GAITHERSBURG, Md. -- The issues surrounding drug-eluting coronary stents remain white hot. The core question is whether they will emerge, in the end, as a great boon to coronary patients or as a lethal insult of major magnitude.

ATLANTA -- Prescription and over-the-counter cough and cold remedies have been linked to the deaths of three infants, CDC researchers here reported.

NEW YORK -- Two drugs, Sutent (sunitinib) and Nexavar (sorafenib), slowed progression of advanced renal-cell carcinoma, investigators reported today, but it was not clear whether either agent would extend overall survival significantly.

TORONTO -- Heart attack survivors who conscientiously take prescribed statins or beta-blockers live longer than those who don't, but that's not so for compliant patients on calcium channel inhibitors, researchers here reported.

CLEVELAND -- In smoking-related head-and-neck squamous-cell carcinoma, genetic alterations in the apparently non-malignant connective tissue and in the epithelium have been found, according to a preliminary study.

SEATTLE -- Parents of a severely cognitively and physically disabled girl have publicly defended their decision to retard her growth through the use of hormonal therapy and surgery, saying they were acting out of love and compassion.

ROCKVILLE, Md. -- The FDA approved a diet drug today that it wants no one to even consider taking. Slentrol (dirlotapide), is an obesity agent for dogs, with nasty side effects if humans try it.